Is Bio-Techne Corporation overvalued?

Bio-Techne Corporation (TECH) — key valuation metrics and fundamentals.

No verdict

Price

$71.01

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$11.10B

Dividend yield

—

Return on equity

—

Sector

Healthcare

Fair value compares TECH's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 29 Jun 2026.

Related stocks